Tag: FDA

Center Joins to Petition the FDA to Improve Treatment for Miscarriage Care

Nearly 50 organizations seek to expand access to essential medications for miscarriage care and remove legal risks to providers and patients.

Citizen Petition to the FDA on the Use of Mifepristone for Miscarriage Management

The Center was one of 49 leading medical and scientific associations, research institutions, and advocacy organizations joining to submit this petition to the FDA on October 4, 2022. It requests that miscarriage management be added as an indication to Mifeprex (mifepristone) and to modify the REMS so that it does not unduly burden its use […]